Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 1
Submit an article Journal homepage
195
Views
21
CrossRef citations to date
0
Altmetric
Review

Ethnic-specific polycystic ovary syndrome: epidemiology, significance and implications

Chandrika N Wijeyaratne Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Colombo, PO Box 271, Kynsey Road, Colombo 008, Sri Lanka; Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Colombo, PO Box 271, Kynsey Road, Colombo 008, Sri Lanka. [email protected]
,
SA Dilini Udayangani Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Colombo, PO Box 271, Kynsey Road, Colombo 008, Sri Lanka; Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Colombo, PO Box 271, Kynsey Road, Colombo 008, Sri Lanka
&
Adam H Balen Leeds Teaching Hospitals, The Leeds Centre for Reproductive Medicine, Seacroft Hospital, Leeds, West Yorkshire, LS14 6UH, UK; Leeds Teaching Hospitals, The Leeds Centre for Reproductive Medicine, Seacroft Hospital, Leeds, West Yorkshire, LS14 6UH, UK
Pages 71-79 | Published online: 10 Jan 2014

References

  • Wijeyaratne CN, Kumarapeli V, Seneviratne RDA et al. Ethnic variations in the expression of polycystic ovary syndrome. In: Current management of Polycystic Ovary Syndrome. RCOG Press, London, UK, 25–45 (2011).
  • Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat. Genet. 39(2), 226–231 (2007).
  • González Burchard E, Borrell LN, Choudhry S et al. Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am. J. Public Health 95(12), 2161–2168 (2005).
  • Risch N, Burchard E, Ziv E, Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol. 3(7), comment 2007 (2002).
  • Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic Ovary Syndrome. Blackwell Scientific, Boston, UK, 377–384 (1992).
  • Rotterdam E. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. (Oxford, England) 19(1), 41 (2004).
  • Azziz R, Carmina E, Dewailly D et al.; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91(2), 456–488 (2009).
  • Wijeyaratne CN, Seneviratne Rde A, Dahanayake S et al. Phenotype and metabolic profile of south Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist endocrine clinic. Hum. Reprod. 26(1), 202–213 (2011).
  • Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among south Asians and caucasians: is there a difference? Clin. Endocrinol. (Oxf.) 57(3), 343–350 (2002).
  • Kumarapeli V, Seneviratne Rde A, Wijeyaratne C. Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women. BJOG 118(3), 319–328 (2011).
  • Carmina E, Ditkoff EC, Malizia G, Vijod AG, Janni A, Lobo RA. Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am. J. Obstet. Gynecol. 167(6), 1819–1824 (1992).
  • Dunaif A, Sorbara L, Delson R, Green G. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean–Hispanic women. Diabetes 42(10), 1462–1468 (1993).
  • Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil. Steril. 63(2), 329–335 (1995).
  • Rodin DA, Bano G, Bland JM, Taylor K, Nussey SS. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin. Endocrinol. (Oxf.) 49(1), 91–99 (1998).
  • Goodarzi MO, Quiñones MJ, Azziz R, Rotter JI, Hsueh WA, Yang H. Polycystic ovary syndrome in Mexican–Americans: prevalence and association with the severity of insulin resistance. Fertil. Steril. 84(3), 766–769 (2005).
  • Misra A, Ganda OP. Migration and its impact on adiposity and Type 2 diabetes. Nutrition 23(9), 696–708 (2007).
  • Bhopal R, Unwin N, White M et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ 319(7204), 215–220 (1999).
  • Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R, Belchetz PE. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin. Endocrinol. (Oxf.) 60(5), 560–567 (2004).
  • Sundararaman PG, Manomani R, Sridhar GR, Sridhar V, Sundaravalli A, Umachander M. Risk of atherosclerosis in women with polycystic ovary syndrome: a study from South India. Metab. Syndr. Relat. Disord. 1(4), 271–275 (2003).
  • Kalra P, Bansal B, Nag P et al. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome. Fertil. Steril. 91(Suppl. 4), 1437–1440 (2009).
  • Welt CK, Arason G, Gudmundsson JA et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J. Clin. Endocrinol. Metab. 91(11), 4361–4368 (2006).
  • Weerakiet S, Bunnag P, Phakdeekitcharoen B et al. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria. Gynecol. Endocrinol. 23(3), 153–160 (2007).
  • Charnvises K, Weerakiet S, Tingthanatikul Y, Wansumrith S, Chanprasertyothin S, Rojanasakul A. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome. Gynecol. Endocrinol. 21(3), 161–164 (2005).
  • Williamson K, Gunn AJ, Johnson N, Milsom SR. The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust. N. Z. J. Obstet. Gynaecol. 41(2), 202–206 (2001).
  • Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91(1), 48–53 (2006).
  • Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90(4), 1929–1935 (2005).
  • Roumain J, Charles MA, de Courten MP et al. The relationship of menstrual irregularity to Type 2 diabetes in Pima Indian women. Diabetes Care 21(3), 346–349 (1998).
  • Solomon CG, Hu FB, Dunaif A et al. Long or highly irregular menstrual cycles as a marker for risk of Type 2 diabetes mellitus. JAMA 286(19), 2421–2426 (2001).
  • Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91(4), 1357–1363 (2006).
  • Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 111(10), 1233–1241 (2005).
  • Finkelstein EA, Khavjou OA, Mobley LR, Haney DM, Will JC. Racial/ethnic disparities in coronary heart disease risk factors among WISEWOMAN enrollees. J. Womens. Health (Larchmt.) 13(5), 503–518 (2004).
  • Coney P, Ladson G, Sweet S, Legro RS. Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African–American women? Semin. Reprod. Med. 26(1), 35–38 (2008).
  • Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum. Reprod. 21(8), 2027–2032 (2006).
  • Chan CNJ, Haines CJ, Chow CCF, Lam PM, Ma CWR, Cheung LP. Polycystic ovarian syndrome in Hong Kong Chinese women: patient characteristics and diagnostic criteria. Hong Kong Med. J. 11(5), 336–341 (2005).
  • Escobar-Morreale HF, Carmina E, Dewailly D et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum. Reprod. Update 18(2), 146–170 (2012).
  • Lin TC, Yen JM, Gong KB et al. Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome among the Taiwanese population – not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism. BMC Med. Genet. 7, 36 (2006).
  • Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum. Reprod. 20(9), 2409–2413 (2005).
  • Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J. Clin. Endocrinol. Metab. 84(11), 4006–4011 (1999).
  • Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85(7), 2434–2438 (2000).
  • Kumarapeli VL, Senevirane R, Wijeyaratne CN, Dodampahala HS. Health seeking behaviour of Sri Lankan women with polycystic ovary syndrome (PCOS). Presented at: 121st Annual Scientific Sessions Sri Lanka Medical Association. Colombo, Sri Lanka, March 2008.
  • Zhang H, Zhu F, Xiong J, Shi X, Fu S. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large scale Chinese population. BJOG 116(12), 1633–1639 (2009).
  • Zhao X, Zhong J, Mo Y, Chen X, Chen Y, Yang D. Association of biochemical hyperandrogenism with Type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 108(2), 148–151 (2010).
  • Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil. Steril. 88(5), 1389–1395 (2007).
  • Vrbíková J, Vondra K, Cibula D et al. Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum. Reprod. 20(12), 3328–3332 (2005).
  • Wijeyaratne CN, Waduge R, Arandara D et al. Metabolic and polycystic ovary syndromes in indigenous south Asian women with previous gestational diabetes mellitus. BJOG 113(10), 1182–1187 (2006).
  • Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am. J. Epidemiol. 168(3), 321–328 (2008).
  • Melo AS, Vieira CS, Romano LG, Ferriani RA, Navarro PA. The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism. Reprod. Sci. 18(12), 1230–1236 (2011).
  • Glintborg D, Mumm H, Hougaard D, Ravn P, Andersen M. Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin. Endocrinol. (Oxf.) 73(6), 732–738 (2010).
  • Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol. Pol. 62(3), 238–242 (2011).
  • Al-Ruhaily AD, Malabu UH, Sulimani RA. Hirsutism in Saudi females of reproductive age: a hospital-based study. Ann. Saudi Med. 28(1), 28–32 (2008).
  • Al-Fozan H, Al-Futaisi A, Morris D, Tulandi T. Insulin responses to the oral glucose tolerance test in women of different ethnicity with polycystic ovary syndrome. J. Obstet. Gynaecol. Can. 27(1), 33–37 (2005).
  • Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur. J. Obstet. Gynecol. Reprod. Biol. 139(1), 59–64 (2008).
  • Vutyavanich T, Khaniyao V, Wongtra-Ngan S, Sreshthaputra O, Sreshthaputra R, Piromlertamorn W. Clinical, endocrine and ultrasonographic features of polycystic ovary syndrome in Thai women. J. Obstet. Gynaecol. Res. 33(5), 677–680 (2007).
  • Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin. Endocrinol. (Oxf.) 51(6), 779–786 (1999).
  • Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J. Clin. Endocrinol. Metab. 83(9), 3078–3082 (1998).
  • March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25(2), 544–551 (2010).
  • Palep-Singh M, Picton HM, Vrotsou K, Maruthini D, Balen AH. South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts. Eur. J. Obstet. Gynecol. Reprod. Biol. 134(2), 202–207 (2007).
  • Lam Pm MR, Cheung LP, Chow CC, Chan JC, Haines CJ. Polycystic ovarian syndrome in Hong Kong Chinese women: patient characteristics and diagnostic criteria. Hong Kong Med. J. 11, 336–341 (2005).
  • Moran LJ, Deeks AA, Gibson-Helm ME, Teede HJ. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum. Reprod. 27(7), 2082–2088 (2012).
  • Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J. Psychosom. Obstet. Gynaecol. 31(1), 24–31 (2010).
  • Schmid J, Kirchengast S, Vytiska-Binstorfer E, Huber J. Psychosocial and sociocultural aspects of infertility – a comparison between Austrian women and immigrant women. Anthropologischer Anzeiger 301–309 (2004).
  • Legro RS, Myers ER, Barnhart HX et al.; Reproductive Medicine Network. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil. Steril. 86(4), 914–933 (2006).
  • Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. For the PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with PCOS. Clin. Endocrinol. Metab. 91, 48–53 (2006).
  • Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am. J. Obstet. Gynecol. 187(5), 1362–1369 (2002).
  • Kauffman RP, Baker VM, DiMarino P, Castracane VD. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome. Fertil. Steril. 85(4), 1010–1016 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.